Zithromac SR



Indications and Reactions:

Role Indications Reactions
Primary
Bronchitis 14.3%
Nasopharyngitis 11.7%
Pharyngitis 9.4%
Pneumonia 9.1%
Upper Respiratory Tract Inflammation 7.9%
Pyrexia 5.7%
Cough 4.9%
Autism 4.5%
Epilepsy 4.5%
Insomnia 3.8%
Cardiac Failure 3.0%
Urinary Tract Infection 3.0%
Hypertension 2.6%
Infection 2.6%
Infection Prophylaxis 2.6%
Asthma 2.3%
Gastritis 2.3%
Analgesic Therapy 1.9%
Constipation 1.9%
Periodontitis 1.9%
Rhabdomyolysis 11.9%
Loss Of Consciousness 8.3%
Hypothermia 6.4%
Pneumonia 6.4%
Vomiting 6.4%
Pyrexia 5.5%
Renal Failure Acute 5.5%
Shock 5.5%
Enterocolitis Haemorrhagic 4.6%
Eosinophilic Pneumonia 4.6%
Oedema 4.6%
Platelet Count Increased 4.6%
Tremor 4.6%
Myalgia 3.7%
Nausea 3.7%
Blood Creatine Phosphokinase Increased 2.8%
Cardiac Failure Acute 2.8%
Cholangitis 2.8%
Diarrhoea 2.8%
Haematochezia 2.8%
Secondary
Bronchitis 16.1%
Pyrexia 9.7%
Pneumonia 8.1%
Angina Pectoris 6.5%
Atypical Pneumonia 6.5%
Atrial Fibrillation 4.8%
Constipation 4.8%
Hypertension 4.8%
Acute Myocardial Infarction 3.2%
Acute Tonsillitis 3.2%
Arteriosclerosis 3.2%
Chlamydial Infection 3.2%
Diabetes Mellitus 3.2%
Gonorrhoea 3.2%
Musculoskeletal Stiffness 3.2%
Nasopharyngitis 3.2%
Oropharyngeal Pain 3.2%
Pharyngitis Bacterial 3.2%
Pneumonia Bacterial 3.2%
Pyelonephritis 3.2%
Loss Of Consciousness 17.6%
Anaphylactic Shock 11.8%
Hepatic Function Abnormal 11.8%
Acute Respiratory Distress Syndrome 5.9%
Altered State Of Consciousness 5.9%
Anti-neutrophil Cytoplasmic Antibody Positive Vasculitis 5.9%
Depressed Level Of Consciousness 5.9%
Eosinophilic Pneumonia 5.9%
Haematuria 5.9%
Hyperglycaemia 5.9%
Interstitial Lung Disease 5.9%
Myalgia 5.9%
Vomiting 5.9%
Concomitant
Pneumonia 41.5%
Hypertension 14.6%
Atrial Fibrillation 9.8%
Organising Pneumonia 7.3%
Cardiac Failure 4.9%
Hiccups 4.9%
Rheumatoid Arthritis 4.9%
Alcoholic Liver Disease 2.4%
Gastrooesophageal Reflux Disease 2.4%
Osteoporosis 2.4%
Prophylaxis Against Gastrointestinal Ulcer 2.4%
Urinary Tract Infection 2.4%
Interstitial Lung Disease 50.0%
Decreased Appetite 25.0%
White Blood Cell Count Increased 25.0%
Interacting
Chronic Obstructive Pulmonary Disease 57.1%
Bronchiolitis 28.6%
Hyperlipidaemia 14.3%
Drug Interaction 100.0%